1. |
Koukourakis MI, Giatromanolaki A, Sivridis E, et al. Beclin-1 over- and underexpression in colorectal cancer: distinct patterns relate to prognosis and tumour hypoxia. Br J Cancer, 2010, 103(8): 1209-1214.
|
2. |
Elbarrawy MA. Comparative immunohistochemical analysis of Beclin-1 & MDM-2 in benign & malignant ameloblastomas. J Immunother Cancer, 2015, 3(Suppl 2): P101.
|
3. |
Ye CL, Yu XL, Liu XQ, et al. Beclin-1 knockdown decreases proliferation, invasion and migration of Ewing sarcoma SK-ES-1 cells via inhibition of MMP-9. Oncol Lett, 2018, 15(3): 3221-3225.
|
4. |
Liu L, Zhao WM, Yang XH, et al. Effect of inhibiting Beclin-1 expression on autophagy, proliferation and apoptosis in colorectal cancer. Oncol Lett, 2017, 14(4): 4319-4324.
|
5. |
董桂兰, 董量, 柯春锦, 等. Beclin1和LC3蛋白在非小细胞肺癌的表达和临床意义. 实用医学杂志, 2017, 33(13): 2097-2100.
|
6. |
Liu J, Lin Y, Yang H, et al. The expression of p33ING1, p53, and autophagy-related gene Beclin1 in patients with non-small cell lung cancer. Tumour Biol, 2011, 32(6): 1113-1121.
|
7. |
Won KY, Kim GY, Lim SJ, et al. Decreased Beclin-1 expression is correlated with the growth of the primary tumor in patients with squamous cell carcinoma and adenocarcinoma of the lung. Hum Pathol, 2012, 43(1): 62-68.
|
8. |
Wang X, Du Z, Li L, et al. Beclin-1 and p62 expression in non-small cell lung cancer: relation with malignant behaviors and clinical outcome. Int J Clin Exp Pathol, 2015, 8(9): 10644-10652.
|
9. |
Song SS, Wang BS, Gu SL, et al. Expression of Beclin-1 and Bcl-2 in pancreatic neoplasms and its effect on pancreatic ductal adenocarcinoma prognosis. Oncol Lett, 2017, 14(6): 7849-7861.
|
10. |
Wang YF, Xie JY, Wang H, et al. Beclin-1 suppresses gastric cancer progression by promoting apoptosis and reducing cell migration. Oncol Lett, 2017, 14(6): 6857-6862.
|
11. |
Huang XJ, Wang CQ, Sun JM, et al. Clinical value of CagA, c-Met, PI3K and Beclin-1 expressed in gastric cancer and their association with prognosis. Oncol Lett, 2018, 15(1): 947-955.
|
12. |
Weh KM, Howell AB, Kresty LA. Expression, modulation, and clinical correlates of the autophagy protein Beclin-1 in esophageal adenocarcinoma. Mol Carcinog, 2016, 55(11): 1876-1885.
|
13. |
Zheng TL, Li DP, He ZF, et al. Prognostic and clinicopathological significance of Beclin-1 in non-small-cell lung cancer: a meta-analysis. Onco Targets Ther, 2018, 11: 4167-4175.
|
14. |
Zhou WH, Yue CF, Deng JY, et al. Autophagic protein beclin-1 serves as an independent positive prognostic biomarker for non-small cell lung cancer. PLoS One, 2013, 8(11): e80338.
|
15. |
李晓颜, 王桂琴. 不同分期肺癌组织中Beclin1、p53、p16表达情况分析. 中国现代医生, 2010, 48(7): 26-27.
|